ID   TAP2_RAT                Reviewed;         703 AA.
AC   P36372;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Antigen peptide transporter 2;
DE            Short=APT2;
DE            EC=7.4.2.14 {ECO:0000305|PubMed:17018292};
DE   AltName: Full=ATP-binding cassette sub-family B member 3;
GN   Name=Tap2; Synonyms=Abcb3, Mtp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1758495; DOI=10.1038/354528a0;
RA   Powis S.J., Townsend A.R.M., Deverson E.V., Bastin J., Butcher G.W.,
RA   Howard J.C.;
RT   "Restoration of antigen presentation to the mutant cell line RMA-S by an
RT   MHC-linked transporter.";
RL   Nature 354:528-531(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS TAP2L PHE-352 AND ARG-603.
RX   PubMed=1350326; DOI=10.1038/357211a0;
RA   Powis S.J., Deverson E.V., Coadwell W.J., Ciruela A., Huskisson N.S.,
RA   Smith H., Butcher G.W., Howard J.C.;
RT   "Effect of polymorphism of an MHC-linked transporter on the peptides
RT   assembled in a class I molecule.";
RL   Nature 357:211-215(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=PVG-RT1L(LEW);
RX   PubMed=8206525; DOI=10.1007/bf00163963;
RA   Joly E., Deverson E.V., Coadwell W.L., Guenther E., Howard J.C.,
RA   Butcher G.W.;
RT   "The distribution of Tap2 alleles among laboratory rat RT1 haplotypes.";
RL   Immunogenetics 40:45-53(1994).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 608-ALA-VAL-609 AND
RP   GLU-632.
RX   PubMed=17018292; DOI=10.1016/j.molcel.2006.07.034;
RA   Procko E., Ferrin-O'Connell I., Ng S.L., Gaudet R.;
RT   "Distinct structural and functional properties of the ATPase sites in an
RT   asymmetric ABC transporter.";
RL   Mol. Cell 24:51-62(2006).
CC   -!- FUNCTION: ABC transporter associated with antigen processing
CC       (PubMed:17018292). In complex with TAP1 mediates unidirectional
CC       translocation of peptide antigens from cytosol to endoplasmic reticulum
CC       (ER) for loading onto MHC class I (MHCI) molecules (By similarity).
CC       Uses the chemical energy of ATP to export peptides against the
CC       concentration gradient (By similarity). During the transport cycle
CC       alternates between 'inward-facing' state with peptide binding site
CC       facing the cytosol to 'outward-facing' state with peptide binding site
CC       facing the ER lumen. Peptide antigen binding to ATP-loaded TAP1-TAP2
CC       induces a switch to hydrolysis-competent 'outward-facing' conformation
CC       ready for peptide loading onto nascent MHCI molecules. Subsequently ATP
CC       hydrolysis resets the transporter to the 'inward facing' state for a
CC       new cycle (By similarity). As a component of the peptide loading
CC       complex (PLC), acts as a molecular scaffold essential for peptide-MHCI
CC       assembly and antigen presentation (By similarity).
CC       {ECO:0000250|UniProtKB:Q03519, ECO:0000269|PubMed:17018292}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a peptide antigen(in) + ATP + H2O = a peptide antigen(out) +
CC         ADP + H(+) + phosphate; Xref=Rhea:RHEA:65972, Rhea:RHEA-COMP:16941,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:166823, ChEBI:CHEBI:456216;
CC         EC=7.4.2.14; Evidence={ECO:0000305|PubMed:17018292};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65973;
CC         Evidence={ECO:0000305|PubMed:17018292};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q03519};
CC   -!- SUBUNIT: Heterodimer of TAP1 and TAP2 (TAP1-TAP2). A component of the
CC       peptide loading complex (PLC), interacts via TAPBP with MHCI
CC       heterodimer; this interaction mediates peptide-MHCI assembly.
CC       {ECO:0000250|UniProtKB:Q03519}.
CC   -!- INTERACTION:
CC       P36372; Q77CE4: gN; Xeno; NbExp=2; IntAct=EBI-11304494, EBI-11303846;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q03519}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=The transmembrane segments seem to form a pore in
CC       the membrane. {ECO:0000250|UniProtKB:Q03519}.
CC   -!- DOMAIN: The peptide-binding site is shared between the cytoplasmic
CC       loops of TAP1 and TAP2. {ECO:0000250|UniProtKB:Q03519}.
CC   -!- DOMAIN: The nucleotide-binding domain (NBD) mediates ATP hydrolysis
CC       coupled to peptide translocation. Two ATP molecules are accommodated at
CC       distinct nucleotide binding sites (NBS) at TAP1-TAP2 dimer interface.
CC       Each NBS is formed by Walker A (GxxGxGKST) and Q-loop motifs from NBD
CC       of one subunit, while the NBD from the second subunit completes the
CC       active site by contributing the C loop motif (LSGGQ). Each ATP molecule
CC       is coordinated via the beta- and gamma-phosphates to a Mg2+ ion, which
CC       is necessary for ATP hydrolysis. {ECO:0000250|UniProtKB:P36370}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB family.
CC       MHC peptide exporter (TC 3.A.1.209) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63854; CAA45339.1; -; mRNA.
DR   EMBL; X75305; CAA53053.1; -; mRNA.
DR   PIR; S38400; S38400.
DR   RefSeq; NP_114445.2; NM_032056.3.
DR   AlphaFoldDB; P36372; -.
DR   SMR; P36372; -.
DR   BioGRID; 246934; 7.
DR   IntAct; P36372; 3.
DR   STRING; 10116.ENSRNOP00000000527; -.
DR   PhosphoSitePlus; P36372; -.
DR   jPOST; P36372; -.
DR   PaxDb; 10116-ENSRNOP00000000527; -.
DR   GeneID; 24812; -.
DR   KEGG; rno:24812; -.
DR   UCSC; RGD:3818; rat.
DR   AGR; RGD:3818; -.
DR   CTD; 6891; -.
DR   RGD; 3818; Tap2.
DR   eggNOG; KOG0058; Eukaryota.
DR   InParanoid; P36372; -.
DR   OrthoDB; 5487044at2759; -.
DR   PhylomeDB; P36372; -.
DR   BRENDA; 7.4.2.14; 5301.
DR   Reactome; R-RNO-1236974; ER-Phagosome pathway.
DR   Reactome; R-RNO-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   PRO; PR:P36372; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0042824; C:MHC class I peptide loading complex; IDA:UniProtKB.
DR   GO; GO:0042825; C:TAP complex; IDA:UniProtKB.
DR   GO; GO:0015433; F:ABC-type peptide antigen transporter activity; ISO:RGD.
DR   GO; GO:0015440; F:ABC-type peptide transporter activity; IBA:GO_Central.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0023029; F:MHC class Ib protein binding; ISO:RGD.
DR   GO; GO:0000166; F:nucleotide binding; IDA:RGD.
DR   GO; GO:0042605; F:peptide antigen binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0046978; F:TAP1 binding; IPI:UniProtKB.
DR   GO; GO:0046979; F:TAP2 binding; IPI:UniProtKB.
DR   GO; GO:0046980; F:tapasin binding; IDA:RGD.
DR   GO; GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; IDA:MGI.
DR   GO; GO:0002485; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; ISO:RGD.
DR   GO; GO:0002489; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent; ISO:RGD.
DR   GO; GO:0002481; P:antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent; ISO:RGD.
DR   GO; GO:0046967; P:cytosol to endoplasmic reticulum transport; ISO:RGD.
DR   GO; GO:0046968; P:peptide antigen transport; ISO:RGD.
DR   GO; GO:0015833; P:peptide transport; IMP:RGD.
DR   GO; GO:0002591; P:positive regulation of antigen processing and presentation of peptide antigen via MHC class I; IMP:RGD.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:MGI.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:UniProtKB.
DR   GO; GO:0002237; P:response to molecule of bacterial origin; ISO:RGD.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   CDD; cd18590; ABC_6TM_TAP2; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR013305; ABC_Tap-like.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005293; Tap2/ABCB3.
DR   InterPro; IPR039421; Type_1_exporter.
DR   NCBIfam; TIGR00958; 3a01208; 1.
DR   PANTHER; PTHR24221:SF237; ANTIGEN PEPTIDE TRANSPORTER 2; 1.
DR   PANTHER; PTHR24221; ATP-BINDING CASSETTE SUB-FAMILY B; 1.
DR   Pfam; PF00664; ABC_membrane; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   PIRSF; PIRSF002773; ABC_prm/ATPase_B; 1.
DR   PRINTS; PR01897; TAP2PROTEIN.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; ATP-binding; Endoplasmic reticulum; Immunity; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Peptide transport;
KW   Protein transport; Reference proteome; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..703
FT                   /note="Antigen peptide transporter 2"
FT                   /id="PRO_0000093331"
FT   TOPO_DOM        1..6
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..27
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        28..56
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        57..77
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        78..98
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        99..119
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        120..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        170..187
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        188..208
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        209..266
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        267..287
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        288..293
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        294..314
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        315..374
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        375..395
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        396..408
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        409..429
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        430..703
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          152..435
FT                   /note="ABC transmembrane type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          468..702
FT                   /note="ABC transporter"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          301..389
FT                   /note="Part of the peptide-binding site"
FT                   /evidence="ECO:0000250|UniProtKB:Q03519"
FT   REGION          414..433
FT                   /note="Part of the peptide-binding site"
FT                   /evidence="ECO:0000250|UniProtKB:Q03519"
FT   BINDING         503..510
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   SITE            16
FT                   /note="Inter-subunit salt bridge with TAPBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q03519"
FT   VARIANT         352
FT                   /note="V -> F (in TAP2L)"
FT                   /evidence="ECO:0000269|PubMed:1350326"
FT   VARIANT         603
FT                   /note="K -> R (in TAP2L)"
FT                   /evidence="ECO:0000269|PubMed:1350326"
FT   MUTAGEN         608..609
FT                   /note="AV->SG: Has negligible effect on ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         632
FT                   /note="E->D: Impairs peptide loading onto MHCI."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         632
FT                   /note="E->Q: Has negligible effect on ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:17018292"
SQ   SEQUENCE   703 AA;  77713 MW;  E545993A8F784250 CRC64;
     MALSHPRPWA SLLLVDLALL GLLQSSLGTL LPPGLPGLWL EGTLRLGVLW GLLKVGGLLR
     LVGTFLPLLC LTNPLFFSLR ALVGSTMSTS VVRVASASWG WLLADYGAVA LSLAVWAVLS
     PAGAQEKEPG QENNRALMIR LLRLSKPDLP FLIVAFIFLA MAVWWEMFIP HYSGRVIDIL
     GGDFDPDAFA SAIFFMCLFS VGSSLSAGCR GGSFLFAESR INLRIREQLF SSLLRQDLAF
     FQETKTGELN SRLSSDTSLM SQWLSLNANI LLRSLVKVVG LYYFMLQVSP RLTFLSLLDL
     PLTIAAEKVY NPRHQAVLKE IQDAVAKAGQ VVREAVGGLQ TVRSFGAEEQ EVRRYKEALE
     RCRQLWWRRD LEKSLYLVIQ RVMALGMQVL ILNVGVQQIL AGEVTRGGLL SFLLYQEEVG
     HHVQNLVYMY GDMLSNVGAA EKVFSYLDRR PNLPNPGTLA PPRLEGRVEF QDVSFSYPSR
     PEKPVLQGLT FTLHPGKVTA LVGPNGSGKS TVAALLQNLY QPTGGQLLLD GEPLVQYDHH
     YLHRQVVLVG QEPVLFSGSV KDNIAYGLRD CEDAQVMAAA QAACADDFIG EMTNGINTEI
     GEKGSQLAVG QKQRLAIARA LVRNPRVLIL DEATSALDAE CEQALQTWRS QEDRTMLVIA
     HRLHTVQNAD QVLVLKQGQL VEHDQLRDEQ DVYAHLVQQR LEA
//
